ARO-SOD1 Injection
AROSOD1-1001
Phase 1 small_molecule terminated
Quick answer
ARO-SOD1 Injection for Amyotrophic Lateral Sclerosis is a Phase 1 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated